Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in

Anyi Liang1, Shanshan Jia2, Fei Gao1

  • 1Department of Ophthalmology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.

Insights

Choriocapillary vascular density (CC VD) is reduced in all stages of Vogt-Koyanagi-Harada (VKH) disease. Optical coherence tomography angiography (OCTA) can monitor VKH activity and predict visual prognosis.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Medical Imaging

Background:

  • Vogt-Koyanagi-Harada (VKH) disease is a systemic inflammatory condition affecting ocular tissues.
  • Changes in choroidal circulation during VKH disease progression are not fully understood.
  • Optical coherence tomography angiography (OCTA) allows for non-invasive assessment of choriocapillary vascular density (CC VD).

Purpose of the Study:

  • To compare CC VD in different stages of VKH disease.
  • To analyze the correlation between CC VD and clinical parameters.
  • To explore the clinical significance of CC VD in VKH disease management.

Main Methods:

  • Retrospective case series including 114 VKH patients and 47 normal controls.
  • OCTA imaging to measure CC VD in acute, convalescent, and chronic recurrent stages of VKH.
  • Comparison of CC VD with best-corrected visual acuity (BCVA) and subfoveal choroidal thickness (SFCT).

Main Results:

  • CC VD was significantly lower in all VKH disease stages compared to normal controls.
  • CC VD increased with inflammation resolution and decreased during anterior uveitis relapse.
  • Lower CC VD in the convalescent stage was associated with a history of anterior recurrence.
  • CC VD showed a negative correlation with BCVA.

Conclusions:

  • CC VD is decreased across all stages of VKH disease.
  • CC VD may serve as a biomarker for monitoring uveitis activity in VKH.
  • OCTA is a valuable tool for evaluating choroidal vascularity and CC VD in VKH patients.
  • Further research is needed to establish OCTA's role in VKH progression monitoring and clinical decision-making.
Abstract